Who Owns Personalis Stock?
NASDAQ: PSNLHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 16.00 0.00%
Ownership breakdown
- Held by institutions
- 66.82%
- Held by insiders
- 26.14%
- Institutional holders
- 223
- Institutions 66.8%
- Insiders 26.1%
- Public and other 7.0%
Who owns Personalis stock?
Institutional investors own about 66.8% of Personalis's shares, spread across 223 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 26.14% of PSNL.
The largest institutional holders are Merck & Co., Inc. (13.41%), ARK Investment Management, LLC (7.90%) and Blackrock Inc. (6.76%). Together, the top 10 institutions control 54.7% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their PSNL positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PSNL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Merck & Co., Inc. | 14.04M | 13.41% | 0.0% |
| ARK Investment Management, LLC | 8.27M | 7.90% | +4.1% |
| Blackrock Inc. | 7.08M | 6.76% | +31.4% |
| Lightspeed Management Company, L.L.C. | 6.10M | 5.83% | -25.2% |
| Ameriprise Financial, Inc. | 6.09M | 5.81% | -19.8% |
| Deep Track Capital, Lp | 4.00M | 3.82% | +33.3% |
| Aberdeen Group plc | 3.75M | 3.58% | +7.4% |
| Vanguard Capital Management LLC | 3.01M | 2.87% | +4.9% |
| Casdin Capital, LLC | 2.55M | 2.44% | +59.4% |
| Kennedy Capital Management, LLC | 2.36M | 2.26% | +8.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PSNL
| Fund | Shares | % Held |
|---|---|---|
| ARK ETF Trust-ARK Genomic Revolution ETF | 6.94M | 6.63% |
| abrdn Healthcare Investors | 2.20M | 2.11% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.14M | 2.05% |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 1.87M | 1.79% |
| iShares Trust-iShares Russell 2000 ETF | 1.75M | 1.67% |
| abrdn Life Sciences Investors | 1.54M | 1.47% |
| Columbia Acorn Trust-Columbia Acorn Fund | 1.28M | 1.22% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 796.07K | 0.76% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 743.35K | 0.71% |
| iShares Trust-iShares Russell 2000 Value ETF | 635.62K | 0.61% |
Frequently asked questions
Who is the largest shareholder of Personalis?
Merck & Co., Inc. is the largest institutional shareholder of PSNL, owning 13.41% of shares outstanding (14.04M shares) as of its latest 13F filing.
What percentage of Personalis is owned by institutions?
Institutions own about 66.8% of PSNL shares and 90.5% of the public float.
How much of Personalis do insiders own?
Insiders, such as officers and directors, own about 26.14% of PSNL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.